New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 7, 2014
07:38 EDTBCR, MDTMedtronic data should lead to approval of drug-coated balloon, says Wells Fargo
Wells fargo believes that data from a trial of Medtronic's drug-coated balloon will lead to approval of the device in 1H15 and establish the company as the market leader in the space. After analyzing data, the firm thinks data on a competing device from C.R. Bard (BCR) could be significantly less positive than the data on Medtronic's product. As a result, the firm anticipates that Medtronic will have a marketing advantage over C.R. Bard. Wells keeps an Outperform rating on Medtronic.
News For MDT;BCR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2015
10:23 EDTBCRC.R. Bard management to meet with JMP Securities
Subscribe for More Information
July 24, 2015
16:22 EDTBCROn The Fly: Top stock stories for Friday
Subscribe for More Information
July 23, 2015
17:33 EDTBCRC.R. Bard sees Q3 EPS $2.21-$2.25, consensus $2.28
Subscribe for More Information
17:32 EDTBCRC.R. Bard raises FY15 EPS view to $9-$9.10 from $8.95-$9.05, consensus $9.02
16:29 EDTBCRC.R. Bard reports Q2 adjusted EPS $2.27, consensus $2.18
Subscribe for More Information
15:04 EDTBCRNotable companies reporting after market close
Subscribe for More Information
July 22, 2015
10:15 EDTMDTThoratec downgraded to Market Perform from Outperform at Northland
Subscribe for More Information
July 21, 2015
09:27 EDTBCRFDA sent C.R. Bard warning letter after facility inspection
The FDA sent C.R. Bard a warning letter after inspecting the company's Peripheral Vascular facility. The letter stated in part, "FDA is aware that your firm submitted both in-vitro and in-vivo testing demonstrating the use of the Recovery Cone Removal System, Model RC-15 for removal of the Recovery Filter (K031328), the G2X Filter (K082305), the G2 Express Filter (K080668), and the G2 Filter (K073090). However, the Recovery Cone System, Model RC-15 was not included as part of the clearances for any of the aforementioned IVC filters. Therefore, your firm is marketing the Recovery Cone Removal System, Model RC-15 in the United States without marketing clearance or approval. Percutaneous retrieval systems, such as the Recovery Cone Removal System, Model RC-15, are regulated as manual surgical instruments intended for specialized use within a specific medical specialty, and thus require marketing authorization in order to be legally marketed in the United States." Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use